Metallothionein protection of cadmium toxicity

Toxicology and Applied Pharmacology

Volumn 238, Issue 3, 2009, Pages 215-220

  Klaassen, Curtis D ^a   Liu, Jie ^b   Diwan, Bhalchandra A ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b National Cancer Institute   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

Acute toxicity; Cadmium; Carcinogenecity; Metallothionein; MT polymorphism; Nephrotoxicity

Indexed keywords

CADMIUM; CADMIUM BINDING PROTEIN; METALLOTHIONEIN;

BILIARY EXCRETION; BONE DISEASE; CADMIUM POISONING; CANCER STAGING; CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; GASTROINTESTINAL ABSORPTION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HALF LIFE TIME; HUMAN; IMMUNOTOXICITY; LIVER TOXICITY; LUNG TOXICITY; NEPHROTOXICITY; NONHUMAN; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SARCOMA; SENSITIVITY ANALYSIS; TOXICOKINETICS;

ANIMALS; CADMIUM; CELL TRANSFORMATION, NEOPLASTIC; ENVIRONMENTAL POLLUTANTS; HUMANS; METALLOTHIONEIN; MICE; NEOPLASMS; PROTEIN BINDING;

EQUIDAE; MUS; MUS MUSCULUS; RODENTIA;

EID: 67649639666     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.03.026     Document Type: Review

References (58)

1. Allan A.K., Hawksworth G.M., Woodhouse L.R., Sutherland B., King J.C., and Beattie J.H. Lymphocyte metallothionein mRNA responds to marginal zinc intake in human volunteers. Br. J. Nutr. 84 (2000) 747-756
2. ATSDR. Toxicological Profile for Cadmium (update) (1999), Agency for Toxic Substances and Disease Registry, Atlanta, Georgia 1-397
3. Cherian M.G., and Kang Y.J. Metallothionein and liver cell regeneration. Exp. Biol. Med. 231 (2006) 138-144
4. Choudhuri S., Liu W.L., Berman N.E., and Klaassen C.D. Cadmium accumulation and metallothionein expression in brain of mice at different stages of development. Toxicol. Lett. 84 (1996) 127-133
5. Crowthers K.C., Kline V., Giardina C., and Lynes M.A. Augmented humoral immune function in metallothionein-null mice. Toxicol. Appl. Pharmacol. 166 (2000) 161-172
6. Dalton T.P., He L., Wang B., Miller M.L., Jin L., Stringer K.F., Chang X., Baxter C.S., and Nebert D.W. Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3401-3406
7. Goering P.L., and Klaassen C.D. Altered subcellular distribution of cadmium following cadmium pretreatment: possible mechanism of tolerance to cadmium-induced lethality. Toxicol. Appl. Pharmacol. 70 (1983) 195-203
8. Goering P.L., and Klaassen C.D. Tolerance to cadmium-induced toxicity depends on presynthesized metallothionein in liver. J. Toxicol. Environ. Health 14 (1984) 803-812
9. Goon D., and Klaassen C.D. Dosage-dependent absorption of cadmium in the rat intestine measured in situ. Toxicol. Appl. Pharmacol. 100 (1989) 41-50
10. Groten J.P., Koeman J.H., van Nesselrooij J.H., Luten J.B., Fentener van Vlissingen J.M., Stenhuis W.S., and van Bladeren P.J. Comparison of renal toxicity after long-term oral administration of cadmium chloride and cadmium-metallothionein in rats. Fundam. Appl. Toxicol. 23 (1994) 544-552
11. Habeebu S.S., Liu J., Liu Y., and Klaassen C.D. Metallothionein-null mice are more susceptible than wild-type mice to chronic CdCl(2)-induced bone injury. Toxicol. Sci. 56 (2000) 211-219
12. Habeebu S.S., Liu J., Liu Y., and Klaassen C.D. Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium. Toxicol. Sci. 55 (2000) 223-232
13. Hart B.A., Voss G.W., and Willean C.L. Pulmonary tolerance to cadmium following cadmium aerosol pretreatment. Toxicol. Appl. Pharmacol. 101 (1989) 447-460
14. Hart B.A., Potts R.J., and Watkin R.D. Cadmium adaptation in the lung - a double-edged sword?. Toxicology 160 (2001) 65-70
15. Jarup L., Berglund M., Elinder C.G., Nordberg G., and Vahter M. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand. J. Work Environ. Health 24 Suppl 1 (1998) 1-51
16. Kagi J.H., and Schaffer A. Biochemistry of metallothionein. Biochemistry 27 (1988) 8509-8515
17. Kita K., Miura N., Yoshida M., Yamazaki K., Ohkubo T., Imai Y., and Naganuma A. Potential effect on cellular response to cadmium of a single-nucleotide A -->G polymorphism in the promoter of the human gene for metallothionein IIA. Hum. Genet. 120 (2006) 553-560
18. Klaassen C.D. Effect of metallothionein on hepatic disposition of metals. Am. J. Physiol. 234 (1978) E47-E53
19. Klaassen C.D., and Liu J. Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity. J. Toxicol. Sci. 23 Suppl 2 (1998) 97-102
20. Klaassen C.D., Liu J., and Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 267-294
21. Lehman L.D., and Klaassen C.D. Dosage-dependent disposition of cadmium administered orally to rats. Toxicol. Appl. Pharmacol. 84 (1986) 159-167
22. Leslie E.M., Liu J., Klaassen C.D., and Waalkes M.P. Acquired cadmium resistance in metallothionein-I/II(-/-) knockout cells: role of the T-type calcium channel Cacnalpha1G in cadmium uptake. Mol. Pharmacol. 69 (2006) 629-639
23. Liu J., Liu Y., and Klaassen C.D. Nephrotoxicity of CdCl2 and Cd-metallothionein in cultured rat kidney proximal tubules and LLC-PK1 cells. Toxicol. Appl. Pharmacol. 128 (1994) 264-270
24. Liu J., and Klaassen C.D. Absorption and distribution of cadmium in metallothionein-I transgenic mice. Fundam. Appl. Toxicol. 29 (1996) 294-300
25. Liu J., Liu Y., Michalska A.E., Choo K.H., and Klaassen C.D. Distribution and retention of cadmium in metallothionein I and II null mice. Toxicol. Appl. Pharmacol. 136 (1996) 260-268
26. Liu J., Liu Y., Michalska A.E., Choo K.H., and Klaassen C.D. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 276 (1996) 1216-1223
27. Liu J., Liu Y., Habeebu S.S., and Klaassen C.D. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex. Toxicol. Sci. 46 (1998) 97-203
28. Liu J., Liu Y., Habeebu S.S., and Klaassen C.D. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats. Toxicol. Appl. Pharmacol. 153 (1998) 48-58
29. Liu J., Liu Y., Habeebu S.S., and Klaassen C.D. Metallothionein-null mice are highly susceptible to the hematotoxic and immunotoxic effects of chronic CdCl2 exposure. Toxicol. Appl. Pharmacol. 159 (1999) 98-108
30. Liu J., Corton C., Dix D.J., Liu Y., Waalkes M.P., and Klaassen C.D. Genetic background but not metallothionein phenotype dictates sensitivity to cadmium-induced testicular injury in mice. Toxicol. Appl. Pharmacol. 176 (2001) 1-9
31. Liu J., Goyer R., and Waalkes M.P. Toxic effects of metals. In: Klaassen C.D. (Ed). Casarett and Doull's Toxicology - the Basic Science of Poisons. 7th Edition (2007), McGraw Hill 931-979
32. Liu J., Cheng M.L., Yang Q., Shan K.R., Shen J., Zhou Y., Zhang X., Dill A.L., and Waalkes M.P. Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China. Environ. Health Perspect. 115 (2007) 1101-1106
33. Liu Y., Liu J., Iszard M.B., Andrews G.K., Palmiter R.D., and Klaassen C.D. Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity. Toxicol. Appl. Pharmacol. 135 (1995) 222-228
34. Liu Y., Liu J., and Klaassen C.D. Metallothionein-null and wild-type mice show similar cadmium absorption and tissue distribution following oral cadmium administration. Toxicol. Appl. Pharmacol. 175 (2001) 253-259
35. Lynes M.A., Zaffuto K., Unfricht D.W., Marusov G., Samson J.S., and Yin X. The physiological roles of extracellular metallothionein. Exp. Biol. Med. 231 (2006) 1548-1554
36. Margoshes M., and Vallee B.L. A cadmium protein from equine kidney cortex. J. Am. Chem. Soc. 79 (1957) 1813-1814
37. Nordberg G.F. Cadmium and health in the 21st century-historical remarks and trends for the future. Biometals 17 (2004) 485-489
38. Nordberg G.F., Goyer R., and Nordberg M. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. Arch. Pathol. 99 (1975) 192-197
39. Oda N., Sogawa C.A., Sogawa N., Onodera K., Furuta H., and Yamamoto T. Metallothionein expression and localization in rat bone tissue after cadmium injection. Toxicol. Lett. 123 (2001) 143-150
40. Onosaka S., Min K.S., Fukuhara C., Tanaka K., Tashiro S., Shimizu I., Furuta M., Yasutomi T., Kobashi K., and Yamamoto K. Concentrations of metallothionein and metals in malignant and non-malignant tissues in human liver. Toxicology 38 (1986) 261-268
41. Park J.D., Liu Y., and Klaassen C.D. Protective effect of metallothionein against the toxicity of cadmium and other metals. Toxicology 163 (2001) 93-100
42. Park J.D., Cherrington N.J., and Klaassen C.D. Intestinal absorption of cadmium is associated with divalent metal transporter 1 in rats. Toxicol. Sci. 68 (2002) 288-294
43. Pearson C.A., Lamar P.C., and Prozialeck W.C. Effects of cadmium on E-cadherin and VE-cadherin in mouse lung. Life Sci. 72 (2003) 1303-1320
44. Prozialeck W.C., Wellington D.R., and Lamar P.C. Comparison of the cytotoxic effects of cadmium chloride and cadmium-metallothionein in LLC-PK1 cells. Life Sci. 53 (1993) 337-342
45. Regunathan A., Glesne D.A., Wilson A.K., Song J., Nicolae D., Flores T., and Bhattacharyya M.H. Microarray analysis of changes in bone cell gene expression early after cadmium gavage in mice. Toxicol. Appl. Pharmacol. 191 (2003) 272-293
46. Takenaka S., Oldiges H., König H., Hochrainer D., and Oberdörster G. Carcinogenicity of cadmium chloride aerosols in W rats. J. Natl. Cancer Inst. 70 (1983) 367-373
47. Taylor B.A., Heiniger H.J., and Meier H. Genetic analysis of resistance to cadmium-induced testicular damage in mice. Proc. Soc. Exp. Biol. Med. 143 (1973) 629-633
48. Waalkes M.P., Perantoni A., Bhave M.R., and Rehm S. Strain dependence in mice of resistance and susceptibility to the testicular effects of cadmium: assessment of the role of testicular cadmium-binding proteins. Appl. Pharmacol 93 (1988) 47-61
49. Waalkes M.P., Perantoni A., and Rehm S. Tissue susceptibility factors in cadmium carcinogenesis. Correlation between cadmium-induction of prostatic tumors in rats and an apparent deficiency of metallothionein. Biol. Trace. Elem. Res. 21 (1989) 483-490
50. Waalkes M.P., Rehm S., and Cherian M.G. Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. Toxicol. Sci. 54 (2000) 110-120
51. Waalkes M.P. Cadmium carcinogenesis. Mutat. Res. 533 (2003) 107-120
52. Waalkes M.P., and Liu J. Metallothionein in inorganic carcinogenesis. In: Sigel A., Sigel H., and Sigel R.K.O. (Eds). Met Ions Life Sci. vol. 5 (2009) 399-412
53. Wang C., Brown S., and Bhattacharyya M.H. Effect of cadmium on bone calcium and 45Ca in mouse dams on a calcium-deficient diet: evidence of Itai-Itai-like syndrome. Toxicol. Appl. Pharmacol. 127 (1994) 320-330
54. Wong K.L., Cachia R., and Klaassen C.D. Comparison of the toxicity and tissue distribution of cadmium in newborn and adult rats after repeated administration. Toxicol. Appl. Pharmacol. 56 (1980) 317-325
55. Wong K.L., and Klaassen C.D. Neurotoxic effects of cadmium in young rats. Toxicol. Appl. Pharmacol. 63 (1982) 330-337
56. Wu M.T., Demple B., Bennett R.A., Christiani D.C., Fan R., and Hu H. Individual variability in the zinc inducibility of metallothionein-IIA mRNA in human lymphocytes. J. Toxicol. Environ. Health 61 (2000) 553-567
57. Zalups R.K. Evidence for basolateral uptake of cadmium in the kidneys of rats. Toxicol. Appl. Pharmacol. 164 (2000) 15-23
58. Zalups R.K., and Ahmad S. Molecular handling of cadmium in transporting epithelia. Toxicol. Appl. Pharmacol. 186 (2003) 163-188